Navigation Links
CryoCath to Hold Third Quarter 2008 Conference Call and Webcast
Date:7/30/2008

http://www.cryocath.com

Toronto Stock Exchange Symbol: CYT

MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its third quarter 2008 financial results at 9:00 a.m. (Eastern Time) on Tuesday, August 5, 2008. The call will be hosted by Mr. Jan Keltjens, President and CEO and Mrs. Ginette Gagne, CFO. The Company will report its results in a press release to be issued at 7:00 a.m on Tuesday, August 5.

DATE: Tuesday, August 5, 2008

TIME: 9:00 a.m., Eastern Time

DIAL IN NUMBER: 416-644-3427 or 1-866-250-4892

TAPED REPLAY: 416-640-1917 or 1-877-289-8525

REFERENCE NUMBER: 21279395 followed by the number sign

WEBCAST: A live audio webcast of the call will be available

at http://www.cryocath.com. Webcast attendees are welcome

to listen to the conference in real-time or

on-demand at their convenience. The webcast will be

archived for 365 days. Please connect to this

website at least 15 minutes prior to the conference

call to ensure adequate time for any software

download that may be needed to hear the webcast.

A question and answer session will follow, at which time the operator will direct participants as to the correct procedure for submitting questions.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias
'/>"/>

SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. CryoCath Appoints Vice President, Europe
2. CryoCath Presents at Prestigious Heart Rhythm Society Meeting
3. CryoCath Announces Fiscal 2008 Second Quarter Results
4. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
5. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
6. CryoCath Introduces Arctic Front in Australia
7. CryoCath Appoints New Chief Financial Officer
8. CryoCath Technologies notice of annual meeting
9. CryoCath Announces Fiscal 2008 First Quarter Results
10. CryoCath Provides Update on Patent Infringement Lawsuit
11. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 1Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 2Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 3Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 4New Survey Takes Important Step in Defining Comprehensive Spine Programs 55275 1New Survey Takes Important Step in Defining Comprehensive Spine Programs 55275 2Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 1Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 2Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 3Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 4